Astera Labs (NASDAQ:ALAB) Trading 4.1% Higher – Should You Buy?

Shares of Astera Labs, Inc. (NASDAQ:ALAB) traded up 4.1% on Friday . The company traded as high as $205.10 and last traded at $202.68. 4,314,034 shares changed hands during trading, a decline of 19% from the average session volume of 5,325,972 shares. The stock had previously closed at $194.74.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on ALAB shares. UBS Group began coverage on shares of Astera Labs in a report on Tuesday, April 21st. They issued a “neutral” rating and a $180.00 target price for the company. Rothschild & Co Redburn initiated coverage on shares of Astera Labs in a report on Friday. They set a “neutral” rating and a $153.00 price target on the stock. Barclays set a $165.00 price target on shares of Astera Labs in a research report on Thursday, January 15th. Royal Bank Of Canada reissued an “outperform” rating and issued a $250.00 price objective on shares of Astera Labs in a research note on Tuesday, April 21st. Finally, Weiss Ratings cut shares of Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Monday, February 23rd. Fifteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $199.20.

Astera Labs Stock Performance

The stock has a fifty day moving average of $139.00 and a 200 day moving average of $153.06. The company has a market capitalization of $34.72 billion, a PE ratio of 166.13, a PEG ratio of 3.99 and a beta of 3.34.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.51 by $0.07. The business had revenue of $270.58 million during the quarter, compared to analyst estimates of $249.46 million. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The company’s revenue was up 91.8% on a year-over-year basis. During the same period last year, the firm posted $0.37 EPS. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. As a group, equities analysts predict that Astera Labs, Inc. will post 1.48 EPS for the current year.

Insider Activity at Astera Labs

In other Astera Labs news, Director Manuel Alba sold 183,000 shares of the business’s stock in a transaction on Wednesday, April 1st. The shares were sold at an average price of $107.61, for a total value of $19,692,630.00. Following the sale, the director owned 319,863 shares in the company, valued at $34,420,457.43. The trade was a 36.39% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 10,188 shares of the stock in a transaction dated Monday, April 20th. The shares were sold at an average price of $175.45, for a total transaction of $1,787,484.60. Following the transaction, the chief executive officer directly owned 4,069,134 shares of the company’s stock, valued at $713,929,560.30. This trade represents a 0.25% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 1,064,888 shares of company stock valued at $150,764,723. 12.50% of the stock is currently owned by insiders.

Institutional Trading of Astera Labs

Large investors have recently added to or reduced their stakes in the company. Lido Advisors LLC grew its holdings in shares of Astera Labs by 0.5% in the fourth quarter. Lido Advisors LLC now owns 12,297 shares of the company’s stock valued at $2,046,000 after purchasing an additional 57 shares in the last quarter. Perigon Wealth Management LLC raised its stake in Astera Labs by 6.2% during the fourth quarter. Perigon Wealth Management LLC now owns 1,252 shares of the company’s stock valued at $208,000 after purchasing an additional 73 shares in the last quarter. Clearstead Advisors LLC raised its stake in Astera Labs by 13.6% during the third quarter. Clearstead Advisors LLC now owns 636 shares of the company’s stock valued at $125,000 after purchasing an additional 76 shares in the last quarter. Sound Income Strategies LLC lifted its position in Astera Labs by 9.2% during the fourth quarter. Sound Income Strategies LLC now owns 902 shares of the company’s stock valued at $164,000 after purchasing an additional 76 shares during the last quarter. Finally, Venturi Wealth Management LLC lifted its position in Astera Labs by 2.6% during the fourth quarter. Venturi Wealth Management LLC now owns 3,284 shares of the company’s stock valued at $546,000 after purchasing an additional 84 shares during the last quarter. Institutional investors own 60.47% of the company’s stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.